Back
Cassava Sciences Vs. Amylyx Pharmaceuticals Industry Stock Comparison
Buy
57
SAVA
Cassava Sciences
Last Price:
22.06
Seasonality Move:
-3.64%
Sell
20
AMLX
Amylyx Pharmaceuticals
Last Price:
2.04
Seasonality Move:
89.63%
Buy
57
Cassava Sciences (SAVA)
is a Buy
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $22.05. The Score for SAVA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- SAVA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy, Sell or Hold?
- The current Amylyx Pharmaceuticals [AMLX] share price is $2.03. The Score for AMLX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- AMLX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $22.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAVA is experiencing selling pressure, which indicates risk of future bearish movement.
AMLX Stock Price Chart
What is Amylyx Pharmaceuticals's stock price today?
-
The Amylyx Pharmaceuticals share price today is $2.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing selling pressure, which indicates risk of future bearish movement.
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 52.16 | Buy |
| Chaikin Money Flow: | -772045 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.12 - 23.42) | Buy |
| Bollinger Bands (100): | (20.66 - 25.76) | Sell |
AMLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 29.35 | Sell |
| Chaikin Money Flow: | -793057 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.84 - 2.5) | Sell |
| Bollinger Bands (100): | (3.86 - 17.2) | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.94 | Buy |
| 20-day SMA: | 22.1 | Sell |
| 50-day SMA: | 21.4 | Buy |
| 200-day SMA: | 21.31 | Buy |
| 8-day EMA: | 21.91 | Buy |
| 20-day EMA: | 21.72 | Buy |
| 50-day EMA: | 21.86 | Buy |
| 200-day EMA: | 22.61 | Sell |
AMLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.89 | Buy |
| 20-day SMA: | 2.06 | Sell |
| 50-day SMA: | 5.75 | Sell |
| 200-day SMA: | 14.43 | Sell |
| 8-day EMA: | 1.95 | Buy |
| 20-day EMA: | 2.36 | Sell |
| 50-day EMA: | 5.18 | Sell |
| 200-day EMA: | 13.49 | Sell |
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $1.67 per share.
Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.96 per share, an increase next quarter of $0.09 per share, a decrease this year of $2.52 per share, and an increase next year of $0.28 per share.
Cassava Sciences Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amylyx Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||